Ignoring Drug Prices Is an Ethical Strikeout

Spencer Hey discuses why high drug pricing is a problem for research ethics

Journal of Bioethical Inquiry
An interdisciplinary forum for ethical and legal debate

Research ignoring drug prices is an ethical strikeout, Center Faculty Spencer Phillips Hey, PhD, argues in the Journal of Bioethical Inquiry. Ignoring the future price of a drug during the research process is in tension with all three of the major principles of research ethics: it fails to show respect for the research participants, undermines the quality of risk/benefit judgements made by ethical review committees, and makes it impossible to judge future patient access and assess justice.

Read the full article